Not Your Father’s Medical Marijuana — Latest Breakthrough in Cannabis Science panel at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Portland, Oregon.
It Can't Hurt to Ask -- Research on Patient Experiences With Medical Cannabis panel at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Portland, Oregon.
It Can't Hurt to Ask -- Research on Patient Experiences With Medical Cannabis panel at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Portland, Oregon.
Not Your Father’s Medical Marijuana — Latest Breakthrough in Cannabis Science panel at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Portland, Oregon.
The Future of Medical Cannabis: Moving Forward and Countering Our Critics panel at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Portland, Oregon.
Medical Marijuana: Clinical Applications, Physiology and Patient Education presentation at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Portland, Oregon.
It Can't Hurt to Ask -- Research on Patient Experiences With Medical Cannabis panel at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Portland, Oregon.
It Can't Hurt to Ask -- Research on Patient Experiences With Medical Cannabis panel at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Portland, Oregon.
It Can't Hurt to Ask -- Research on Patient Experiences With Medical Cannabis panel at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Portland, Oregon.
Medical Cannabis: The Moral Imperative, Institutional Impediment, Individual Discrimination and the End of the ‘Medical’ Cannabis Industry Post Prohibition speech at the 39th NORML National Conference, September 9-11, 2010, Governor Hotel, Port
Ross Mirkarimi is on the San Francisco Board of Supervisors. He receives an award from NORML for his work bringing about working Marijuana Law Reform. Presented by Marcia Rosenbaum PhD of the Drug Policy Alliance. First we hear NORML Executive